Načítá se...
“Drugs to avoid” to improve quality use of medicines: how is Australia faring?
BACKGROUND: Each year, the French independent bulletin Prescrire publishes a list of medicines, “Drugs to avoid”, that should not be used in clinical practice as their risk-to-benefit ratio is unfavourable. This study assessed the market approval, reimbursement and use of these medicines in Australi...
Uloženo v:
| Vydáno v: | J Pharm Policy Pract |
|---|---|
| Hlavní autoři: | , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
BioMed Central
2021
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8278758/ https://ncbi.nlm.nih.gov/pubmed/34256874 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40545-021-00346-3 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|